RecruitingNCT06123897
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In ChangshaSchizophreniaObservational study
- Countries
- China
- Sponsor
- Central South University
RecruitingEUCTR 2022-001582-12
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BarcelonaSchizophreniaHistorical research record
- Countries
- Spain
- Sponsor
- Consorcio Centro de Investigacion Biomedica en Red (CIBER)
RecruitingNCT07105111
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including BryantSchizophrenia, Depression, ...Medication studyAges 18+
- Countries
- United States
- Sponsor
- Neurocrine Biosciences
RecruitingNCT04580134
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including HartfordSchizophrenia, BipolarityMedication studyAges 18–60
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
RecruitingNCT06865937
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In San DiegoSchizophreniaBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- University of California, San Diego
RecruitingNCT07379827
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including BryantSchizophreniaObservational studyAges 18+
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb
RecruitingNCT06898879
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In AlbuquerqueSchizophrenia, Depression, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development
RecruitingNCT06740890
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In New YorkSchizophrenia, BipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
RecruitingNCT07234708
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In BarcelonaSchizophreniaInterventional studyAges 18+
- Countries
- Spain
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
RecruitingNCT06286202
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In SingaporeSchizophreniaBehavioural studyAges 21–60
- Countries
- Singapore
- Sponsor
- Singapore Institute of Technology
RecruitingNCT07085923
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In OsloSchizophrenia, BipolarityBehavioural studyAges 25–70
- Countries
- Norway
- Sponsor
- Madeleine Elisabeth Angelsen
RecruitingNCT04945278
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In BoharsSchizophreniaInterventional studyAges 15–25
- Countries
- France
- Sponsor
- University Hospital, Brest
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
Get research updates
